EU Merger Regulation 139/2004: 20 Years that Made a Difference

 EC, Video here. 

Non-price competition in EU merger control

 EC, Policy Brief here. 

The Relationship between Competition and Innovation (Part I)

 OECD Competition Policy Roundtable, here. 

Statement Regarding Termination of CooperCompanies’ Attempted Acquisition of Cook Medical’s Reproductive Health Business

 FTC, here.

Merger control in the digital age – Challenges and development perspectives

 Bundeskartellamt, here. 

A “Whack-a-mole monopolization machine”?“. Ecosystem” theories in digital platform mergers

 CEPR, Video here. 

Big tech companies snap up smaller rivals at record pace

FT, here.  

PLATFORM MERGERS AND ANTITRUST

 G. Parker et al., here. 

Innovation Considerations in Horizontal Merger Control

 Antitrust Digest, here. 

Big-Tech Mergers: Innovation, Competition for the Market, and the Acquisition of Emerging Competitors

M. Katz, here. 

Sequences & Sparks : Life Sciences Innovation Mergers

Our Curious Amalgam Podcast, here.

[Note to self: Tokyo Electron/Applied Materials here]

Innovation Considerations in Horizontal Merger Control

I. Kokkoris, T. Valletti, here. 

Mergers, Product Prices, and Innovation: Evidence from the Pharmaceutical Industry

A. Bonaime, Ye (Emma) Wang, here. 

Illumina has abandoned its anticipated $1.2 billion takeover of PacBio

CMA, here.
FTC, here. 

FTC Challenges Illumina’s Proposed Acquisition of PacBio

FTC, here. 

Sanofi will Biotechfirma Synthorx für 2,5 Milliarden Dollar kaufen

Handelsblatt, hier. 

Assessing Innovation Theories of Harm in EU Merger Control

S. Solidoro, here. 

Summaries of the various written contributions received for the discussion on "Merger control in dynamic markets"

OECD, here. 

Unearthing the complete set of harms to patients and innovation

R. Chopra, here. 

U.S. v. Sabre: Putting the Innovation Theory of Harm to the Test?

Orrick, here.